In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.

Success with agents starts with embedding them in workflows, not letting them run amok. Context, skills, models, and tools are key. There’s more.

Explore how DFMEA transforms product development by identifying potential risks, optimizing designs, and ensuring compliance with regulatory standards.